| For: | Zhou Q, He Q, Liang LJ. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. World J Gastroenterol 2003; 9(11): 2450-2454 [PMID: 14606074 DOI: 10.3748/wjg.v9.i11.2450] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2450.htm |
| Number | Citing Articles |
| 1 |
J.W. Park, K.W. Lee, S.J. Kim, S.H. Choi, J.S. Heo, C.H.D. Kwon, D.J. Kim, Y.S. Han, S.K. Lee, J.W. Joh. Outcome of Patients With Recurrent Hepatocellular Carcinoma in Liver Transplantation. Transplantation Proceedings 2006; 38(7) doi: 10.1016/j.transproceed.2006.06.030
|
| 2 |
Hai Bin Chen, Ke Pan, Mei Kuen Tang, Yiu Loon Chui, Ling Chen, Zhong Jing Su, Zhong Ying Shen, En Min Li, Wei Xie, Kenneth K.H. Lee. Comparative proteomic analysis reveals differentially expressed proteins regulated by a potential tumor promoter, BRE, in human esophageal carcinoma cells. Biochemistry and Cell Biology 2008; 86(4) doi: 10.1139/O08-069
|
| 3 |
Ching-Wen Huang, Ching-Yih Lin, Hsuan-Ying Huang, Hui-Wen Liu, Yi-Ju Chen, Deng-Fuh Shih, Hong-Yaw Chen, Chung-Chou Juan, Chen-Guo Ker, Chi-Ying F. Huang, Chien-Feng Li, Yow-Ling Shiue. CKS1B Overexpression Implicates Clinical Aggressiveness of Hepatocellular Carcinomas but Not p27Kip1 Protein Turnover: an Independent Prognosticator with Potential p27Kip1-Independent Oncogenic Attributes?. Annals of Surgical Oncology 2010; 17(3) doi: 10.1245/s10434-009-0779-8
|
| 4 |
Siu Tim Cheung, Ronnie T. Poon. Signaling Pathways in Liver Diseases. 2005; doi: 10.1007/3-540-27194-5_27
|
| 5 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|
| 6 |
Xia Zhao, Weihua Yang, Changwen Shi, Wanshan Ma, Jianing Liu, Yunshan Wang, Guosheng Jiang. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells. Tumor Biology 2011; 32(2) doi: 10.1007/s13277-010-0126-5
|
| 7 |
Li Zhao, Dong-Cheng Mou, Xi-Sheng Leng, Ji-Run Peng, Wan-Xiang Wang, Lei Huang, Shu Li, Ji-Ye Zhu. Expression of cancer-testis antigens in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(14): 2034-2038 doi: 10.3748/wjg.v10.i14.2034
|
| 8 |
Abeer A. Bahnassy, Abdel-Rahman N. Zekri, Samah A. Loutfy, Waleed S. Mohamed, Amrallah Abdel Moneim, Salem E. Salem, Marwa M. Sheta, Ashraf Omar, Heba Al-Zawahry. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma. Experimental and Molecular Pathology 2011; 91(2) doi: 10.1016/j.yexmp.2011.06.014
|
| 9 |
WEIHUA YANG, XIA ZHAO, FENGYAN PEI, MINGYU JI, WANSHAN MA, YUNSHAN WANG, GUOSHENG JIANG. Activation of the intrinsic apoptosis pathway contributes to the induction of apoptosis in hepatocellular carcinoma cells by valproic acid. Oncology Letters 2015; 9(2) doi: 10.3892/ol.2014.2739
|
| 10 |
Sintim Mui, Juanyi Shi, Kai Wen, Yongcong Yan, Huoming Li, Weidong Wang, Zhenyu Zhou, Zhiyu Xiao. Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinoma. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02066-5
|
| 11 |
Giovannella Bruscalupi, Mara Massimi, Laura Conti Devirgiliis, Silvia Leoni. Multiple parameters are involved in the effects of cadmium on prenatal hepatocytes. Toxicology in Vitro 2009; 23(7) doi: 10.1016/j.tiv.2009.07.018
|
| 12 |
Yadong Wang, Yingzheng Zhao, Xiaoyu Chen. Experimental Study on the Estrogen-Like Effect of Boric Acid. Biological Trace Element Research 2008; 121(2) doi: 10.1007/s12011-007-8041-3
|
| 13 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_174
|
| 14 |
Nils-Holger Zschemisch, Christian Liedtke, Uta Dierssen, Yulia A. Nevzorova, Torsten Wüstefeld, Jürgen Borlak, Michael P. Manns, Christian Trautwein. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo. Hepatology 2006; 44(1) doi: 10.1002/hep.21224
|
| 15 |
Azza E El Bassiouny, Mona M Nosseir, Mona K Zoheiry, Noha A Ameen, Ahmed M Abdel-Hadi, Ibrahim M Ibrahim, Suher Zada, Abdel-Hakeem Saad El-Deen, Nora E El-Bassiouni. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World Journal of Hepatology 2010; 2(1): 32-41 doi: 10.4254/wjh.v2.i1.32
|
| 16 |
Kian Chuan Sia, Hung Huynh, Alexander Yaw Fui Chung, London Lucien Peng Jin Ooi, Kiat Hon Lim, Kam Man Hui, Paula Yeng Po Lam. Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model. Molecular Cancer Therapeutics 2013; 12(8) doi: 10.1158/1535-7163.MCT-13-0056
|
| 17 |
Ke-Jun Nan, Zhao Jing, Ling Gong. Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(10): 1425-1430 doi: 10.3748/wjg.v10.i10.1425
|
| 18 |
Jonathan Cools-Lartigue, Jonathan Spicer. Experimental and Clinical Metastasis. 2013; doi: 10.1007/978-1-4614-3685-0_7
|
| 19 |
Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven Curley, Yuman Fong, Gregory Gores, Robert Kerlan, Phillipe Merle, Bert O'Neil, Ronnie Poon, Lawrence Schwartz, Joel Tepper, Francis Yao, Daniel Haller, Margaret Mooney, Alan Venook. Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting. Journal of Clinical Oncology 2010; 28(25) doi: 10.1200/JCO.2010.28.7805
|
| 20 |
Rolf Aamodt, Kristin Jonsdottir, Solveig Norheim Andersen, Johan Bondi, Geir Bukholm, Ida R. K. Bukholm. Differences in Protein Expression and Gene Amplification of Cyclins between Colon and Rectal Adenocarcinomas. Gastroenterology Research and Practice 2009; 2009 doi: 10.1155/2009/285830
|
| 21 |
Supama Mazumder, Dragos Plesca, Alexandru Almasan. Application of Apoptosis to Cancer Treatment. 2005; doi: 10.1007/1-4020-3302-8_6
|
| 22 |
Hong Yang, Xin Zhang, Xiao-yong Cai, Dong-yue Wen, Zhi-hua Ye, Liang Liang, Lu Zhang, Han-lin Wang, Gang Chen, Zhen-bo Feng. From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma. PeerJ 2017; 5 doi: 10.7717/peerj.3089
|
| 23 |
Marwa Matboli, Hiba S. Al-Amodi, Abdelrahman Khaled, Radwa Khaled, Marwa Ali, Hala F. M. Kamel, Manal S. Abd EL Hamid, Hind A. ELsawi, Eman K. Habib, Ibrahim Youssef. Integrating molecular, biochemical, and immunohistochemical features as predictors of hepatocellular carcinoma drug response using machine-learning algorithms. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1430794
|
| 24 |
Chiun Hsu, Liang-In Lin, Yu-Che Cheng, Zi-Rui Feng, Yu-Yun Shao, Ann-Lii Cheng, Da-Liang Ou. Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression. Clinical Cancer Research 2016; 22(10) doi: 10.1158/1078-0432.CCR-15-0499
|
| 25 |
C.H. Golias, A. Charalabopoulos, K. Charalabopoulos. Cell proliferation and cell cycle control: a mini review. International Journal of Clinical Practice 2004; 58(12) doi: 10.1111/j.1742-1241.2004.00284.x
|
| 26 |
Yohei Saito, Yoshikazu Kuwahara, Yumi Yamamoto, Masatoshi Suzuki, Manabu Fukumoto, Fumihiko Yamamoto. ddY Mice Fed 10% Fat Diet Exhibit High p27KIP Expression and Delayed Hepatocyte DNA Synthesis During Liver Regeneration. Metabolic Syndrome and Related Disorders 2018; 16(6) doi: 10.1089/met.2017.0131
|
| 27 |
Yasunobu Matsuda, Toshifumi Wakai, Masayuki Kubota, Masaaki Takamura, Satoshi Yamagiwa, Yutaka Aoyagi, Mami Osawa, Shun Fujimaki, Ayumi Sanpei, Takuya Genda, Takafumi Ichida. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma. Medical Molecular Morphology 2013; 46(4) doi: 10.1007/s00795-013-0047-7
|
| 28 |
C Wan, S Hou, R Ni, L Lv, Z Ding, X Huang, Q Hang, S He, Y Wang, C Cheng, X X Gu, G Xu, A Shen. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene 2015; 34(2) doi: 10.1038/onc.2013.536
|
| 29 |
Yongxiang Luo, Zhaoyin Fu, Peisheng Wu, Dawu Zheng, Xiumei Zhang. The clinicopathological and prognostic significance of P27kip in hepatocellular carcinoma patients: A systemic review and meta-analysis. Gene 2020; 734 doi: 10.1016/j.gene.2020.144351
|
| 30 |
Riaan Conradie, Frank J. Bruggeman, Andrea Ciliberto, Attila Csikász‐Nagy, Bela Novák, Hans V. Westerhoff, Jacky L. Snoep. Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex. The FEBS Journal 2010; 277(2) doi: 10.1111/j.1742-4658.2009.07473.x
|
| 31 |
Sven C.D. van IJzendoorn, Delphine Théard, Johanna M. van der Wouden, Willy Visser, Kacper A. Wojtal, Dick Hoekstra. Oncostatin M-stimulated Apical Plasma Membrane Biogenesis Requires p27Kip1-Regulated Cell Cycle Dynamics. Molecular Biology of the Cell 2004; 15(9) doi: 10.1091/mbc.e04-03-0201
|
| 32 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_174-1
|
| 33 |
Leyon Varghese, Chapla Agarwal, Alpana Tyagi, Rana P. Singh, Rajesh Agarwal. Silibinin Efficacy against Human Hepatocellular Carcinoma. Clinical Cancer Research 2005; 11(23) doi: 10.1158/1078-0432.CCR-05-1646
|
| 34 |
Cheerapinya Taebprakhon, Supannika Sorin, Kullanat Khawkhiaw, Chatchai Phoomak, Wunchana Seubwai, Sopit Wongkham, Charupong Saengboonmee. Pro-Tumorigenic Roles of Cyclin Dependent Kinase 2 and its Associated Cyclins in Cholangiocarcinoma Progression under High Glucose Condition. Archives of Medical Research 2026; 57(3) doi: 10.1016/j.arcmed.2026.103383
|
| 35 |
Yasunobu Matsuda. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1734-1740 doi: 10.3748/wjg.14.1734
|
| 36 |
Yulia A. Nevzorova, Christian Trautwein. Liver Regeneration. 2015; doi: 10.1016/B978-0-12-420128-6.00011-7
|
| 37 |
Chinatsu Kasuga, Yukiko Nakahara, Shigeo Ueda, Cynthia Hawkins, Michael D. Taylor, Christian A. Smith, James T. Rutka. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Journal of Neurosurgery: Pediatrics 2008; 1(4) doi: 10.3171/PED/2008/1/4/305
|
| 38 |
Yan Geng, Wojciech Michowski, Joel M. Chick, Yaoyu E. Wang, M. Emmanuelle Jecrois, Katharine E. Sweeney, Lijun Liu, Richard C. Han, Nan Ke, Agnieszka Zagozdzon, Ewa Sicinska, Roderick T. Bronson, Steven P. Gygi, Piotr Sicinski. Kinase-independent function of E-type cyclins in liver cancer. Proceedings of the National Academy of Sciences 2018; 115(5) doi: 10.1073/pnas.1711477115
|
| 39 |
Hui‐Ching Wang, Wenya Huang, Ming‐Der Lai, Ih‐Jen Su. Hepatitis B virus pre‐S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Science 2006; 97(8) doi: 10.1111/j.1349-7006.2006.00235.x
|